Single agents |
---|
Doxorubicin |
Ifosfamide |
Epirubicin |
Gemcitabine |
Dacarbazine |
Liposomal doxorubicin |
Temozolomide |
Vinorelbine |
Eribulin |
Trabectedin |
Pazopanib |
Regorafenib |
Larotrectinib |
Combination regimens |
---|
AD: doxorubicin, dacarbazine |
AIM: doxorubicin, ifosfamide, mesna |
MAID: mesna, doxorubicin, ifosfamide, dacarbazine |
Ifosfamide, epirubicin, mesna |
Gemcitabine and docetaxel |
Gemcitabine and vinorelbine |
Gemcitabine and dacarbazine |
Doxorubicin and olaratumab (October 2016- July 2018 only) |